Winterstein Appointed Chair of FDA Committee

Almut Winterstein, PhD
Professor; UF Graduate Program in POP Research
Graduate Coordinator

The University of Florida’s College of Pharmacy is pleased to announce that Dr. Almut Winterstein, Professor in the Department of Pharmaceutical Outcomes and Policy, has been appointed chair of the FDA Drug Safety and Risk Management Advisory Committee.

The Drug Safety And Risk Management Committee advises the Commissioner of Food and Drugs on risk management, risk communication, and quantitative evaluation of spontaneous reports for drugs for human use and for any other product for which the Food and Drug Administration has regulatory responsibility.

The Committee also advises the Commissioner of Food and Drugs regarding the scientific and medical evaluation of all information gathered by the Department of Health and Human Services and the Department of Justice with regard to safety, efficacy, and abuse potential of drugs or other substances, and recommends actions to be taken by the Department of Health and Human Services with regard to the marketing, investigation, and control of such drugs or other substances.